Literature DB >> 25957901

Stem cell patents after the america invents act.

Jacob S Sherkow1, Christopher Thomas Scott2.   

Abstract

Under the newly passed Leahy-Smith America Invents Act (AIA), the U.S. Patent and Trademark Office may hear new challenges to stem cell patents. Here, we explore how the new law affects challenges to stem cell patents, focusing on two recent cases, and discuss the future of stem cell patent disputes.
Copyright © 2015 Elsevier Inc. All rights reserved.

Mesh：

Year:  2015        PMID： 25957901     DOI： 10.1016/j.stem.2015.04.015

Source DB:  PubMed          Journal:  Cell Stem Cell        ISSN： 1875-9777            Impact factor:   24.633


  2 in total

Review 1.  Patent Application Trends of Induced Pluripotent Stem Cell Technologies in the United States, Japanese, and European Applications.

Authors:  Yasushi Morita; Hanayuki Okura; Akifumi Matsuyama
Journal:  Biores Open Access       Date:  2019-03-19

2.  Interfacing of Science, Medicine and Law: The Stem Cell Patent Controversy in the United States and the European Union.

Authors:  Sonya Davey; Neil Davey; Qian Gu; Na Xu; Rajet Vatsa; Samir Devalaraja; Paul Harris; Sreenivas Gannavaram; Raj Dave; Ananda Chakrabarty
Journal:  Front Cell Dev Biol       Date:  2015-11-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.